Your browser doesn't support javascript.
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries.
Godman, Brian; Egwuenu, Abiodun; Haque, Mainul; Malande, Oliver Ombeva; Schellack, Natalie; Kumar, Santosh; Saleem, Zikria; Sneddon, Jacqueline; Hoxha, Iris; Islam, Salequl; Mwita, Julius; do Nascimento, Renata Cristina Rezende Macedo; Dias Godói, Isabella Piassi; Niba, Loveline Lum; Amu, Adefolarin A; Acolatse, Joseph; Incoom, Robert; Sefah, Israel Abebrese; Opanga, Sylvia; Kurdi, Amanj; Chikowe, Ibrahim; Khuluza, Felix; Kibuule, Dan; Ogunleye, Olayinka O; Olalekan, Adesola; Markovic-Pekovic, Vanda; Meyer, Johanna C; Alfadl, Abubakr; Phuong, Thuy Nguyen Thi; Kalungia, Aubrey C; Campbell, Stephen; Pisana, Alice; Wale, Janney; Seaton, R Andrew.
  • Godman B; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
  • Egwuenu A; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
  • Haque M; School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Penang 11800, Malaysia.
  • Malande OO; AMR Programme Manager, Nigeria Centre for Disease Control (NCDC), Ebitu Ukiwe Street, Jabi, Abuja 240102, Nigeria.
  • Schellack N; Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, Kuala Lumpur 57000, Malaysia.
  • Kumar S; Department of Child Health and Paediatrics, Egerton University, Nakuru, P.O. Box 536, Egerton 20115, Kenya.
  • Saleem Z; East Africa Centre for Vaccines and Immunization (ECAVI), Namela House, Naguru, Kampala P.O. Box 3040, Uganda.
  • Sneddon J; Faculty of Health Sciences, Basic Medical Sciences Building, University of Pretoria, Prinshof 349-Jr, Pretoria 0084, South Africa.
  • Hoxha I; Department of Periodontology and Implantology, Karnavati University, Gandhinagar 382422, India.
  • Islam S; Department of Pharmacy Practice, Faculty of Pharmacy, The University of Lahore, Lahore 54000, Pakistan.
  • Mwita J; Healthcare Improvement Scotland, Delta House, 50 West Nile Street, Glasgow G1 2NP, UK.
  • do Nascimento RCRM; Department of Pharmacy, Faculty of Medicine, University of Medicine Tirana, 1005 Tirana, Albania.
  • Dias Godói IP; Department of Microbiology, Jahangirnagar University, Savar, Dhaka 1342, Bangladesh.
  • Niba LL; Department of Internal Medicine, Faculty of Medicine, University of Botswana, Private Bag 0022, Gaborone, Botswana.
  • Amu AA; Department of Pharmacy, Postgraduate Program in Pharmaceutical Sciences (CiPharma), School of Pharmacy, Federal University of Ouro Preto, Ouro Preto 35400-000, Minas Gerais, Brazil.
  • Acolatse J; Institute of Health and Biological Studies, Universidade Federal do Sul e Sudeste do Pará, Avenida dos Ipês, s/n, Cidade Universitária, Cidade Jardim, Marabá 68500-00, Pará, Brazil.
  • Incoom R; Center for Research in Management, Society and Epidemiology, Universidade do Estado de Minas Gerais, Belo Horizonte 31270-901, MT, Brazil .
  • Sefah IA; Effective Basic Services (eBASE) Africa, Ndamukong Street, Bamenda P.O Box 5175, Cameroon.
  • Opanga S; Department of Public Health, University of Bamenda, Bambili P.O. Box 39, Cameroon.
  • Kurdi A; Pharmacy Department, Eswatini Medical Christian University, P.O. Box A624, Swazi Plaza, Mbabane H101, Eswatini.
  • Chikowe I; Pharmacy Directorate, Cape Coast Teaching Hospital (CCTH), Cape Coast, Ghana.
  • Khuluza F; Pharmacy Directorate, Cape Coast Teaching Hospital (CCTH), Cape Coast, Ghana.
  • Kibuule D; Pharmacy Department, Keta Municipal Hospital, Ghana Health Service, Keta-Dzelukope, Ghana.
  • Ogunleye OO; Pharmacy Practice Department of Pharmacy Practice, School of Pharmacy, University of Health and Allied Sciences, Ho, Volta Region, Ghana.
  • Olalekan A; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi P.O. Box 30197-00100, Kenya.
  • Markovic-Pekovic V; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
  • Meyer JC; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil 44001, Iraq.
  • Alfadl A; Pharmacy Department, College of Medicine, Chichiri 30096, Blantyre 3, Malawi.
  • Phuong TNT; Pharmacy Department, College of Medicine, Chichiri 30096, Blantyre 3, Malawi.
  • Kalungia AC; Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek 13301, Namibia.
  • Campbell S; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Ikeja, Lagos 100271, Nigeria.
  • Pisana A; Department of Medicine, Lagos State University Teaching Hospital, Ikeja, Lagos 100271, Nigeria.
  • Wale J; Department of Medical Laboratory Science, University of Lagos, Idiaraba, Lagos 100271, Nigeria.
  • Seaton RA; Centre for Genomics of Non-Communicable Diseases and Personalized Healthcare (CGNPH), University of Lagos, Akoka, Lagos 100271, Nigeria.
Life (Basel) ; 11(6)2021 Jun 07.
Article in English | MEDLINE | ID: covidwho-1282529
ABSTRACT
Antimicrobial resistance (AMR) is a high priority across countries as it increases morbidity, mortality and costs. Concerns with AMR have resulted in multiple initiatives internationally, nationally and regionally to enhance appropriate antibiotic utilization across sectors to reduce AMR, with the overuse of antibiotics exacerbated by the COVID-19 pandemic. Effectively tackling AMR is crucial for all countries. Principally a narrative review of ongoing activities across sectors was undertaken to improve antimicrobial use and address issues with vaccines including COVID-19. Point prevalence surveys have been successful in hospitals to identify areas for quality improvement programs, principally centering on antimicrobial stewardship programs. These include reducing prolonged antibiotic use to prevent surgical site infections. Multiple activities centering on education have been successful in reducing inappropriate prescribing and dispensing of antimicrobials in ambulatory care for essentially viral infections such as acute respiratory infections. It is imperative to develop new quality indicators for ambulatory care given current concerns, and instigate programs with clear public health messaging to reduce misinformation, essential for pandemics. Regular access to effective treatments is needed to reduce resistance to treatments for HIV, malaria and tuberculosis. Key stakeholder groups can instigate multiple initiatives to reduce AMR. These need to be followed up.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials / Reviews Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Life11060528

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Randomized controlled trials / Reviews Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Life11060528